Atovaquone 250MG/proguanil HCL 100MG order #3

Ended Awarded Last action

Contract number
75D30123F16816
Awardee
Awarding agency
Obligated
$24,647

Award facts

Contract value 100% obligated
$24,647.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Mason, OH 45040, USA

Award details come from SAM.gov/FPDS.

About this award

Prasco, LLC was awarded a $24,647.04 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to provide 250mg/100mg doses of atovaquone/proguanil hydrochloride for the Centers for Disease Control and Prevention (CDC). The order is for Product #3 under the schedule and must be completed by August 15, 2023. Performance will take place in Mason, Ohio. No set-aside provisions were applied to this award to supply anti-malarial drugs in support of the CDC's global disease prevention programs.

Quick answers

Who was awarded contract 75D30123F16816?

75D30123F16816 was awarded to Prasco, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 9, 2023.

How much is contract 75D30123F16816 worth?

The government has obligated $24,647 on 75D30123F16816.

Is contract 75D30123F16816 an order under another contract?

Yes. 75D30123F16816 is a delivery order under 36F79721D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75D30123F16816 competed?

The extent of competition for 75D30123F16816 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award